Drugs / Shanghai Biological Quadrivalent Influenza Virus Inactivated Vaccine
Shanghai Biological Quadrivalent Influenza Virus Inactivated Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT06827873 Background | Feb → May 2025 overdue | — | Tsinghua University | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shanghai Biological Quadrivalent Influenza Virus Inactivated Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06827873 ↗ |
| Modality | Vaccine | “Shanghai Biological Quadrivalent Influenza Virus Inactivated Vaccine” NCT06827873 ↗ |
| Route | Intramuscular | “suitable for intramuscular injection in individuals 6 months and older.” NCT06827873 ↗ |